If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs
Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes
But our team has learned over years of meticulous work that true success, the kind that leads to repeatable and reliable data, often hinges on the small, seemingly mundane details
Dihexa has a more directly characterized cognitive enhancement profile and favorable oral bioavailability, but carries the burden of a retracted key publication and theoretical oncological concerns from HGF/c-Met activation
Combination Peptide Therapy Many patients benefit from a broader peptide therapy for injuries plan that may include multiple healing peptides designed to support recovery, energy, and tissue repair
Adult neurogenesis and mental illness